Autoantibodies & Long Covid
Researchers have identified several biomarkers correlating with long Covid symptoms, further suggesting an autoimmune process activating one year post-Covid infection.
Read More »
Antibodies
COVID-19 Severity and Autoantibody Production
To better characterize the immunopathology of COVID-19, researchers studied the range of autoantibodies triggered by a SARS-CoV-2 infection, as well as infection severity. Generally, the autoantibodies in patients with mild COVID-19 only slightly differed compared to healthy controls. Patients with moderate COVID-19 exhibited more elevated autoantibody counts, whereas those with severe COVID-19 were observed to have the highest levels of autoantibodies.
Read More »COVID-19 Drives Autoimmunity
This Week in Virology podcast discusses the finding that infection with SARS-CoV-2 leads to an increase in new and preexisting autoantibodies. Find the episode here!
Read More »COVID-19 Boosters in Autoimmune Rheumatic and Musculoskeletal Patients
Researchers in Hungary investigated the efficacy of COVID-19 boosters in patients with autoimmune rheumatic and musculoskeletal diseases. They also studied whether a SARS-CoV-2 infection following a two-dose primary series increased antibody production by the immune system in lieu of a booster.
Read More »